Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02511236 · ClinicalTrials.gov registry record · Phase 4
Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention
A Phase 4 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 356
- Enrollment target
NCT02511236: Completed Phase 4 study, sponsored by University of Miami.
NCT02511236 is a Phase 4 study that has completed, run by University of Miami. The registered enrollment target is 356 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (31% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02511236, a Phase 4 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 356 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effects of a group smoking cessation program. The study will also examine individual differences in response to the intervention program.
Primary Outcome
Reported will be the number of participants reporting 7 day point prevalence of smoking abstinence
Interventions
- DRUG Transdermal Nicotine Patch
- BEHAVIORAL General Health Education
- BEHAVIORAL Group Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 356 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-10-23 |
| Phase | Phase 4 |
What the finished NCT02511236 record still lists
NCT02511236 is an interventional study that assigns participants to a tested intervention. The registered 356 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (31% lower).
The record links to 0 conditions, and to 3 interventions - of which Transdermal Nicotine Patch is the first listed.
NCT02511236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02511236 about?
NCT02511236 is a clinical study titled "Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention". The purpose of this study is to test the effects of a group smoking cessation program. The study will also examine individual differences in response to the intervention program.
What is the current status of trial NCT02511236?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 356 participants. The study started on 2015-08. Estimated completion is 2019-10-23.
What interventions are being tested in trial NCT02511236?
The interventions under investigation include: Transdermal Nicotine Patch (DRUG), General Health Education (BEHAVIORAL), Group Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02511236?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02511236's enrollment target sits among peer trials
356 228th of 2000 higher than 1,773 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
- NCT06958328 · 356 participants · Phase 3
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- NCT06960993 · 356 participants · NA
Mosaic Trial for Stem Cell Transplant Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia